[{"Assets_0_Q2_USD":825151000.0,"CommonStockSharesOutstanding_0_Q2_shares":129421788.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-58058000.0,"NetIncomeLoss_1_Q2_USD":-65382000.0,"NetIncomeLoss_2_Q2_USD":-111547000.0,"StockholdersEquity_0_Q2_USD":549752000.0,"Ticker":"PGEN","CIK":"1356090","name":"INTREXON CORP","OfficialName":"Precigen Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337298902.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180813"}]